Mirae Asset Global Etfs Holdings Ltd. Adaptive Biotechnologies Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 65,916 shares of ADPT stock, worth $544,466. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,916
Previous 63,291
4.15%
Holding current value
$544,466
Previous $324,000
21.91%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADPT
# of Institutions
224Shares Held
146MCall Options Held
19.6KPut Options Held
27.2K-
Viking Global Investors LP30MShares$248 Million0.61% of portfolio
-
Rubric Capital Management LP New York, NY14.6MShares$121 Million1.45% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$96.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$88.5 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.42MShares$77.8 Million0.49% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.18B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...